Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Md. Emrul Hasan Bappi"'
Autor:
Kakon Nag, Md. Jikrul Islam, Md. Maksudur Rahman Khan, Md. Mashfiqur Rahman Chowdhury, Md. Enamul Haq Sarker, Samir Kumar, Habiba Khan, Sourav Chakraborty, Rony Roy, Raton Roy, Md. Shamsul Kaunain Oli, Uttam Barman, Md. Emrul Hasan Bappi, Bipul Kumar Biswas, Mohammad Mohiuddin, Naznin Sultana
Recombinant human erythropoietin (rhEPO) has been saving millions of lives worldwide as a potent and safe treatment for the lack of erythrocyte, which is caused by chronic kidney disease (CKD) and other issues. Several biosimilars of rhEPO have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b51fbe0c25ae40b849d0f8531ffa2a9
https://doi.org/10.1101/2023.01.22.525046
https://doi.org/10.1101/2023.01.22.525046
Autor:
Kakon Nag, Md. Enamul Haq Sarker, Samir Kumar, Sourav Chakraborty, Habiba Khan, Md. Jikrul Islam, Md. Maksusdur Rahman Khan, Md. Mashfiqur Rahman Chowdhury, Rony Roy, Ratan Roy, Bipul Kumar Biswas, Md. Emrul Hasan Bappi, Mohammad Mohiuddin, Naznin Sultana
Well-characterized and scalable downstream process for purification of biologics is extremely demanding for delivering quality therapeutics to patients at a reasonable price. Erythropoietin (EPO) is a blockbuster biologic with diverse clinical applic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e3f8742c309c52890d1a4fcc350020c
https://doi.org/10.1101/2023.01.18.524508
https://doi.org/10.1101/2023.01.18.524508